AKT1 and autoimmune polyendocrinopathy: Additionally, alterations in Interferon, IL-6/JAK/STAT3, PI3K/AKT/mTOR, and ILT-STAT4 signaling pathways highlight the thromboinflammatory milieu that defines APS, including NoAPS.